106 related articles for article (PubMed ID: 26982362)
1. Cancer Immunosurveillance Caught in the Act.
Berraondo P; Teijeira A; Melero I
Immunity; 2016 Mar; 44(3):525-526. PubMed ID: 26982362
[TBL] [Abstract][Full Text] [Related]
2. Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability.
Mlecnik B; Bindea G; Angell HK; Maby P; Angelova M; Tougeron D; Church SE; Lafontaine L; Fischer M; Fredriksen T; Sasso M; Bilocq AM; Kirilovsky A; Obenauf AC; Hamieh M; Berger A; Bruneval P; Tuech JJ; Sabourin JC; Le Pessot F; Mauillon J; Rafii A; Laurent-Puig P; Speicher MR; Trajanoski Z; Michel P; Sesboüe R; Frebourg T; Pagès F; Valge-Archer V; Latouche JB; Galon J
Immunity; 2016 Mar; 44(3):698-711. PubMed ID: 26982367
[TBL] [Abstract][Full Text] [Related]
3. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome.
Galon J; Costes A; Sanchez-Cabo F; Kirilovsky A; Mlecnik B; Lagorce-Pagès C; Tosolini M; Camus M; Berger A; Wind P; Zinzindohoué F; Bruneval P; Cugnenc PH; Trajanoski Z; Fridman WH; Pagès F
Science; 2006 Sep; 313(5795):1960-4. PubMed ID: 17008531
[TBL] [Abstract][Full Text] [Related]
4. Molecular diagnostics and colorectal cancer.
Wong W
Manag Care; 2010 Nov; 19(11):41. PubMed ID: 21141376
[No Abstract] [Full Text] [Related]
5. Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer.
Nosho K; Sukawa Y; Adachi Y; Ito M; Mitsuhashi K; Kurihara H; Kanno S; Yamamoto I; Ishigami K; Igarashi H; Maruyama R; Imai K; Yamamoto H; Shinomura Y
World J Gastroenterol; 2016 Jan; 22(2):557-66. PubMed ID: 26811607
[TBL] [Abstract][Full Text] [Related]
6. Elevated plasma IL-22 levels correlated with Th1 and Th22 cells in patients with immune thrombocytopenia.
Cao J; Chen C; Zeng L; Li L; Li X; Li Z; Xu K
Clin Immunol; 2011 Oct; 141(1):121-3. PubMed ID: 21652269
[No Abstract] [Full Text] [Related]
7. T Helper Lymphocyte Subsets and Plasticity in Autoimmunity and Cancer: An Overview.
Ivanova EA; Orekhov AN
Biomed Res Int; 2015; 2015():327470. PubMed ID: 26583100
[TBL] [Abstract][Full Text] [Related]
8. Treg-cell depletion promotes chemokine production and accumulation of CXCR3(+) conventional T cells in intestinal tumors.
Akeus P; Langenes V; Kristensen J; von Mentzer A; Sparwasser T; Raghavan S; Quiding-Järbrink M
Eur J Immunol; 2015 Jun; 45(6):1654-66. PubMed ID: 25754875
[TBL] [Abstract][Full Text] [Related]
9. Anti-HER2 CD4(+) T-helper type 1 response is a novel immune correlate to pathologic response following neoadjuvant therapy in HER2-positive breast cancer.
Datta J; Berk E; Xu S; Fitzpatrick E; Rosemblit C; Lowenfeld L; Goodman N; Lewis DA; Zhang PJ; Fisher C; Roses RE; DeMichele A; Czerniecki BJ
Breast Cancer Res; 2015 May; 17(1):71. PubMed ID: 25997452
[TBL] [Abstract][Full Text] [Related]
10. The unfulfilled promise of molecular diagnosis in colorectal cancer.
Golfinopoulos V; Hendlisz A
Curr Opin Oncol; 2010 Jul; 22(4):362-3. PubMed ID: 20473163
[No Abstract] [Full Text] [Related]
11. Increased tumor infiltration by mucosal-associated invariant T cells correlates with poor survival in colorectal cancer patients.
Zabijak L; Attencourt C; Guignant C; Chatelain D; Marcelo P; Marolleau JP; Treiner E
Cancer Immunol Immunother; 2015 Dec; 64(12):1601-8. PubMed ID: 26497850
[TBL] [Abstract][Full Text] [Related]
12. [T cell subsets, Th1/Th2, and allergy].
Nariuchi H
Arerugi; 1998 Jun; 47(6):570-2. PubMed ID: 9721447
[No Abstract] [Full Text] [Related]
13. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J
Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
[TBL] [Abstract][Full Text] [Related]
14. How dense, how intense? Role of tumour-infiltrating lymphocytes across colorectal cancer stages. Re: Nosho et al. Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review. J Pathol 2010; 222: 350-366.
Laghi L; Bianchi P; Grizzi F; Malesci A
J Pathol; 2011 Dec; 225(4):628; author reply 629-30. PubMed ID: 21826670
[No Abstract] [Full Text] [Related]
15. [Analysis of peripheral blood T cell subsets in children with idiopathic thrombocytopenic purpura].
Xiao H; Liu F; Wu CL; Yang XM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Aug; 14(4):722-5. PubMed ID: 16928308
[TBL] [Abstract][Full Text] [Related]
16. Existence of Th22 in children and evaluation of IL-22 + CD4 + T, Th17, and other T cell effector subsets from healthy children compared to adults.
Shen E; Wang M; Xie H; Zou R; Lin Q; Lai L; Li F; Liang Z; Xu Y; Zhou M
BMC Immunol; 2016 Jun; 17(1):20. PubMed ID: 27338754
[TBL] [Abstract][Full Text] [Related]
17. Th1 and Th2 T helper cell subsets affect patterns of injury and outcomes in glomerulonephritis.
Holdsworth SR; Kitching AR; Tipping PG
Kidney Int; 1999 Apr; 55(4):1198-216. PubMed ID: 10200982
[TBL] [Abstract][Full Text] [Related]
18. Increased numbers of monocyte-derived dendritic cells during successful tumor immunotherapy with immune-activating agents.
Kuhn S; Hyde EJ; Yang J; Rich FJ; Harper JL; Kirman JR; Ronchese F
J Immunol; 2013 Aug; 191(4):1984-92. PubMed ID: 23858033
[TBL] [Abstract][Full Text] [Related]
19. Tumor-infiltrating dendritic cell subsets of progressive or regressive tumors induce suppressive or protective immune responses.
Liu Y; Bi X; Xu S; Xiang J
Cancer Res; 2005 Jun; 65(11):4955-62. PubMed ID: 15930318
[TBL] [Abstract][Full Text] [Related]
20. Multiple roles for CD4+ T cells in anti-tumor immune responses.
Kennedy R; Celis E
Immunol Rev; 2008 Apr; 222():129-44. PubMed ID: 18363998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
